elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q45862308-345BC31D-5E7A-421F-8D7C-08EE0BC02A0C
Q45862308-345BC31D-5E7A-421F-8D7C-08EE0BC02A0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45862308-345BC31D-5E7A-421F-8D7C-08EE0BC02A0C
Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease.
P2860
Q45862308-345BC31D-5E7A-421F-8D7C-08EE0BC02A0C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45862308-345BC31D-5E7A-421F-8D7C-08EE0BC02A0C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
007cd75a3c18a3a0fb6f3bdcb8a1d85453c3e330
P2860
Risks and benefits of infliximab for the treatment of Crohn's disease